Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

605.61
+15.612.65%
Post-market: 605.10-0.5100-0.08%19:53 EDT
Volume:1.61M
Turnover:974.86M
Market Cap:65.41B
PE:15.36
High:615.61
Open:600.00
Low:599.08
Close:590.00
Loading ...

Regeneron Exec Says Potential Impact From Sector-Specific Tariffs Is Not Quantifiable at This Time -Conf Call

THOMSON REUTERS
·
29 Apr

Regeneron (REGN) Lags Q1 Earnings and Revenue Estimates

Zacks
·
29 Apr

BUZZ-Regeneron Pharma falls after quarterly results miss

Reuters
·
29 Apr

Regeneron Shares Down 6.9% Premarket After Q1 Results Miss Estimates

THOMSON REUTERS
·
29 Apr

Regeneron 1Q Profit Rises, Revenue Falls; FY25 CapEx Target Trimmed

Dow Jones
·
29 Apr

Regeneron Pharmaceuticals Q1 2025 Earnings: GAAP EPS of $7.27 Misses Estimate, Revenue Falls Short at $3.0 Billion

GuruFocus
·
29 Apr

Regeneron: Q1 Earnings Snapshot

Associated Press Finance
·
29 Apr

Regeneron Pharmaceuticals' Q1 Adjusted Earnings, Revenue Fall

MT Newswires Live
·
29 Apr

Regeneron reports Q1 adjusted EPS $8.22, consensus $8.48

TIPRANKS
·
29 Apr

MORNING BID U.S.-Trade fears ebb, Canada's Carney returns

Reuters
·
29 Apr

The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron

Zacks
·
29 Apr

BRIEF-Regeneron Q1 Adjusted EPS USD 8.22 Vs. IBES Estimate USD 8.82

Reuters
·
29 Apr

Regeneron Pharmaceuticals Q1 Adj. EPS $8.22 Misses $8.82 Estimate, Sales $3.03B Miss $3.29B Estimate

Benzinga
·
29 Apr

Regeneron Reports First Quarter 2025 Financial and Operating Results

THOMSON REUTERS
·
29 Apr

Regeneron Pharmaceuticals Inc: Q1 2025 Dupixent(®) Global Net Sales (Recorded by Sanofi) Increased 19% to $3.67 Bln

THOMSON REUTERS
·
29 Apr

Regeneron Q1 EPS USD 7.27

THOMSON REUTERS
·
29 Apr

Regeneron Outlook FY Capex USD 850-950 Million

THOMSON REUTERS
·
29 Apr

Regeneron Reports First Quarter 2025 Financial and Operating Results

GlobeNewswire
·
29 Apr

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
29 Apr

What to Watch in the Day Ahead - Tuesday, April 29

Reuters
·
29 Apr